Creating a Bridging Study to Support Shelf Life Extension
When a pharmaceutical company seeks to extend the shelf life of a drug product, but full long-term stability data isn’t yet available on new batches or updated formulations, a bridging study becomes an essential regulatory strategy. A well-designed bridging study uses existing data from previous batches to justify a shelf life extension for new production…
Read More “Creating a Bridging Study to Support Shelf Life Extension” »